UrologyNews.net

Urology Xagena

Search results for "Androgen deprivation therapy"

Androgen deprivation therapy, which blocks steroid hormones called androgens, is used in around 50% of prostate cancer patients. It is recommended for locally advanced and metastatic prostate cancer. ...


In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy ( ADT ) was associated with a significantly increased risk of acute kidney injury, ...


In a phase III clinical trial, the hormone therapy Enzalutamide ( Xtandi ) extended survival in men with metastatic prostate cancer that had progressed during treatment with androgen deprivation thera ...


A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy ( ADT ), a testosterone-lowering therapy and a common treatment for ...